<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">bekhterev</journal-id><journal-title-group><journal-title xml:lang="ru">Обозрение психиатрии и медицинской психологии имени В.М.Бехтерева</journal-title><trans-title-group xml:lang="en"><trans-title>V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2313-7053</issn><issn pub-type="epub">2713-055X</issn><publisher><publisher-name>V. M. BEKHTEREV  NATIONAL  RESEARCH  MEDICAL  CENTER  FOR  PSYCHIATRY  AND  NEUROLOGY                           OF    THE  RUSSIAN  FEDERATION   MINISTRY  OF  HEALTH</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31363/2313-7053-2024-1033</article-id><article-id custom-type="elpub" pub-id-type="custom">bekhterev-1075</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>НАУЧНЫЕ ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>SCIENTIFIC REVIEW</subject></subj-group></article-categories><title-group><article-title>Коморбидность депрессии и метаболического синдрома: к вопросу о каузальных или ассоциативных связях</article-title><trans-title-group xml:lang="en"><trans-title>Comorbidity of depression and metabolic syndrome: on the question of causal or associative connections</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4096-6208</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Петрова</surname><given-names>Н. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Petrova</surname><given-names>N. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Петрова Наталия Николаевна - д.м.н. профессор, заведующая кафедрой психиатрии и наркологии</p><p>197022, г. Санкт-Петербург, ул. Льва Толстого, 6-8</p></bio><bio xml:lang="en"><p>Natalia N. Petrova</p><p>St. Petersburg</p></bio><email xlink:type="simple">petrova_nn@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-2798-8800</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Семенова</surname><given-names>Н. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Semenova</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Семенова Наталия Владимировна - д.м.н., заместитель директора</p><p>192019, СанктПетербург, ул. Бехтерева, д. 3</p></bio><bio xml:lang="en"><p>Natalia V. Semenova</p><p>St. Petersburg</p><p> </p></bio><email xlink:type="simple">nvs@bekhterev.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5470-4359</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Малышко</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Malyshko</surname><given-names>L. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Малышко Лариса Владимировна - младший научный сотрудник научно-организационного отделения</p><p>192019, СанктПетербург, ул. Бехтерева, д. 3</p></bio><bio xml:lang="en"><p>Larisa V. Malyshko</p><p>St. Petersburg</p></bio><email xlink:type="simple">lora5497@yandex.ru</email><xref ref-type="aff" rid="aff-3"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Санкт-Петербургского государственного университета</institution><country>Россия</country></aff><aff xml:lang="en"><institution>St. Petersburg State University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр психиатрии и неврологии им.  В.М. Бехтерева» Минздрава России по научно-организационной и методической работе</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр психиатрии и неврологии им. В.М. Бехтерева» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>16</day><month>12</month><year>2024</year></pub-date><volume>58</volume><issue>4-2</issue><fpage>39</fpage><lpage>46</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Петрова Н.Н., Семенова Н.В., Малышко Л.В., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Петрова Н.Н., Семенова Н.В., Малышко Л.В.</copyright-holder><copyright-holder xml:lang="en">Petrova N.N., Semenova N.V., Malyshko L.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.bekhterevreview.com/jour/article/view/1075">https://www.bekhterevreview.com/jour/article/view/1075</self-uri><abstract><p>Проблема частой коморбидности между депрессией и метаболическим синдромом известна медицине давно. Однако, появляется все больше данных о совместном течении данных состояний. В нарративном обзоре представлены актуальные научные данные о взаимосвязи метаболического синдрома и депрессии, а также результаты исследований влияния антидепрессантов на развитие метаболических нарушений. Обзор базируется на анализе 75 публикаций, размещенных в библиографических базах РИНЦ и Medline.</p><p>Несмотря на многочисленные результаты исследований, доказывающих коморбидность депрессии и метаболического синдрома, вопрос об их причинно-следственной связи остается открытым. Представленные материалы дополняют представления об ассоциациях метаболического синдрома и депрессии, а также позволяют учитывать механизмы коморбидности данных состояний при выборе антидепрессантов.</p></abstract><trans-abstract xml:lang="en"><p>The problem of frequent comorbidity between depression and metabolic syndrome has been known to medicine for a long time. However, there is more and more data on the joint course of these states. The narrative review presents current scientific data on the relationship between metabolic syndrome and depression, as well as the results of studies on the effect of antidepressants on the development of metabolic disorders. The review is based on an analysis of 75 publications published in the bibliographic databases of the RSCI and Medline. Despite numerous research results proving the comorbidity of depression and metabolic syndrome, the question of their causal relationship remains open. The presented materials complement the understanding of the associations of metabolic syndrome and depression, and also allow us to take into account the mechanisms of comorbidity of these conditions when choosing antidepressants.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>депрессия</kwd><kwd>метаболический синдром</kwd><kwd>антидепрессанты.</kwd><kwd>сахарный диабет</kwd><kwd>индекс массы тела</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование выполнено в рамках государственного задания ФГБУ «НМИЦ ПН им. В.М. Бехтерева» Минздрава России 2024-2026 гг. (XSOZ 2024 0012)</funding-statement><funding-statement xml:lang="en">The study was performed within the framework of the state assignment of the «V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology of the Ministry of Health of Russia» 2024-2026 (XSOZ 2024 0012).</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Павлова Т.А., Доровских И.В., Горобец Л.Н. Метаболические нарушения, связанные с применением антидепрессантов. Психиатрия и психофармакотерапия. 2016;18(6):37–40.</mixed-citation><mixed-citation xml:lang="en">Pavlova TA, Dorovskikh IV, Gorobets LN. Metabolic disorders associated with the use of antidepressants. Psihiatriya i psihofarmakoterapiya. 2016;18(6):37-40. (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Akbaraly TN, Ancelin ML, Jaussent I, Ritchie C, Barberger-Gateau P, Dufouil C, et al. Metabolic syndrome and onset of depressive symptoms in the elderly: findings from the three-city study. Diabetes Care. 2011;34:904-909.</mixed-citation><mixed-citation xml:lang="en">Akbaraly TN, Ancelin ML, Jaussent I, Ritchie C, Barberger-Gateau P, Dufouil C, et al. Metabolic syndrome and onset of depressive symptoms in the elderly: findings from the three-city study. Diabetes Care. 2011;34:904-909.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Akbaraly TN, Kivimaki M, Brunner EJ, Chandola T, Marmot MG, Singh-Manoux A, et al. Association between metabolic syndrome and depressive symptoms in middle-aged adults: results from the Whitehall II study. Diabetes Care. 2009;32:499-504.</mixed-citation><mixed-citation xml:lang="en">Akbaraly TN, Kivimaki M, Brunner EJ, Chandola T, Marmot MG, Singh-Manoux A, et al. Association between metabolic syndrome and depressive symptoms in middle-aged adults: results from the Whitehall II study. Diabetes Care. 2009;32:499-504.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epi- demiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atheroscle- rosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-5. https://doi.org/10.1161/CIRCULA-TIONAHA.109.192644.</mixed-citation><mixed-citation xml:lang="en">Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epi- demiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atheroscle- rosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640-5. https://doi.org/10.1161/CIRCULA-TIONAHA.109.192644.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Al-Khatib Y, Akhtar MA, Kanawati MA, Mucheke R, Mahfouz M, Al-Nufoury M. Depression and Metabolic Syndrome: A Narrative Review. Cureus. 2022;14(2):e22153.</mixed-citation><mixed-citation xml:lang="en">Al-Khatib Y, Akhtar MA, Kanawati MA, Mucheke R, Mahfouz M, Al-Nufoury M. Depression and Metabolic Syndrome: A Narrative Review.  Cureus. 2022;14(2):e22153.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Bahrami S, Steen NE, Shadrin A, O’Connell K, Frei O, Bettella F, et al. Shared Genetic Loci between Body Mass Index and Major Psychiatric Disorders: A Genome-wide Association Study. JAMA Psychiatry. 2020;77(5):503-512.</mixed-citation><mixed-citation xml:lang="en">Bahrami S, Steen NE, Shadrin A, O’Connell K, Frei O, Bettella F, et al.  Shared Genetic Loci between Body Mass Index and Major Psychiatric Disorders: A Genome-wide Association Study. JAMA Psychiatry.  2020;77(5):503-512.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Bakhtiari A, Hashemi M, Hosseini SR, Omidvar S, Bijani A, Khairkhah F. The relationship between depression and metabolic syndrome in the elderly population: the cohort aging study. Iran J Psychiatry. 2018;13:230-238.</mixed-citation><mixed-citation xml:lang="en">Bakhtiari A, Hashemi M, Hosseini SR, Omidvar S, Bijani A, Khairkhah F. The relationship between depression and metabolic syndrome in the elderly population: the cohort aging study. Iran J Psychiatry. 2018;13:230-238.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Barnard K, Peveler RC, Holt RI. Antidepressant medication as a risk factor for type 2 diabetes and impaired glucose regulation: systematic review. Di- abetes Care. 2013;36(10):3337-45.</mixed-citation><mixed-citation xml:lang="en">Barnard K, Peveler RC, Holt RI. Antidepressant medication as a risk factor for type 2 diabetes and impaired glucose regulation: systematic review. Di- abetes Care. 2013;36(10):3337-45.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Benedetti F, Poletti S, Hoogenboezem TA, Locatelli C, de Wit H, Wijkhuijs AJM, Colombo C, Drexhage HA. Higher Baseline Proinflammatory Cytokines Mark Poor Antidepressant Response in Bipolar Disorder. J Clin Psychiatry. 2017;78(8):e986-e993.</mixed-citation><mixed-citation xml:lang="en">Benedetti F, Poletti S, Hoogenboezem TA, Locatelli C, de Wit H, Wijkhuijs AJM, Colombo C, Drexhage HA. Higher Baseline Proinflammatory Cytokines Mark Poor Antidepressant Response in Bipolar Disorder. J Clin Psychiatry. 2017;78(8):e986-e993.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Bilska K, Dmitrzak-Węglarz M, Osip P, Pawlak J, Paszyńska E, Permoda-Pachuta A. Metabolic Syndrome and Adipokines Profile in Bipolar Depression. Nutrients. 2023;15(21):4532.</mixed-citation><mixed-citation xml:lang="en">Bilska K, Dmitrzak-Węglarz M, Osip P, Pawlak J, Paszyńska E, Permoda-Pachuta A. Metabolic Syndrome and Adipokines Profile in Bipolar Depression. Nutrients. 2023;15(21):4532.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Burrage E, Marshall KL, Santanam N, Chantler PD. Cerebrovascular dysfunction with stress and depression. Brain Circ. 2018;4(2):43-53.</mixed-citation><mixed-citation xml:lang="en">Burrage E, Marshall KL, Santanam N, Chantler PD. Cerebrovascular dysfunction with stress and depression. Brain Circ. 2018;4(2):43-53.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Chan JYC, Yiu KKL, Kwok TCY, Wong SYS, Tsoi KKF. Depression and Antidepressants as Potential Risk Factors in Dementia: A Systematic Review and Meta-analysis of 18 Longitudinal Studies. J Am Med Dir Assoc. 2019;20(3):279-286.e1.</mixed-citation><mixed-citation xml:lang="en">Chan JYC, Yiu KKL, Kwok TCY, Wong SYS, Tsoi KKF. Depression and Antidepressants as Potential Risk Factors in Dementia: A Systematic Review and Meta-analysis of 18 Longitudinal Studies. J Am Med Dir Assoc. 2019;20(3):279-286.e1.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Chan JYC, Yiu KKL, Kwok TCY, Wong SYS, Tsoi KKF. Depression and Antidepressants as Potential Risk Factors in Dementia: A Systematic Review and Meta-analysis of 18 Longitudinal Studies. J Am Med Dir Assoc. 2019;20(3):279-286.e1.</mixed-citation><mixed-citation xml:lang="en">Chan JYC, Yiu KKL, Kwok TCY, Wong SYS, Tsoi KKF. Depression and Antidepressants as Potential Risk Factors in Dementia: A Systematic Review and Meta-analysis of 18 Longitudinal Studies. J Am Med Dir Assoc. 2019;20(3):279-286.e1.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Chan KL, Cathomas F, Russo SJ. Central and Peripheral Inflammation Link Metabolic Syndrome and Major Depressive Disorder. Physiology (Bethesda). 2019;34(2):123-133.</mixed-citation><mixed-citation xml:lang="en">Chan KL, Cathomas F, Russo SJ. Central and Peripheral Inflammation Link Metabolic Syndrome and Major Depressive Disorder. Physiology (Bethesda). 2019;34(2):123-133.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Choi KW, Chen CY, Stein MB, Klimentidis YC, Wang MJ, Koenen KC, et al. Assessment of bidirectional relationships between physical activity and depression among adults: a 2-sample Mendelian randomization study. JAMA Psychiatry. 2019;76:399-408.</mixed-citation><mixed-citation xml:lang="en">Choi KW, Chen CY, Stein MB, Klimentidis YC, Wang MJ, Koenen KC, et al. Assessment of bidirectional relationships between physical activity and depression among adults: a 2-sample Mendelian randomization study. JAMA Psychiatry. 2019;76:399-408.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Correll CU, Detraux J, De Lepeleire J, De Hert M. Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disor- der. World Psychiatry. 2015;14(2):119-136.</mixed-citation><mixed-citation xml:lang="en">Correll CU, Detraux J, De Lepeleire J, De Hert M. Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disor- der. World Psychiatry. 2015;14(2):119-136.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Demirci H, Cinar Y, Bilgel N. Metabolic syndrome and depressive symptoms in a primary health care setting in Turkey. Bulletin Clin Psy-chopharmacol. 2011;21(1):49-57.</mixed-citation><mixed-citation xml:lang="en">Demirci H, Cinar Y, Bilgel N. Metabolic syndrome and depressive symptoms in a primary health care setting in Turkey. Bulletin Clin Psy-chopharmacol. 2011;21(1):49-57.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Dregan A, Rayner L, Davis KAS, Bakolis I, Arias de la Torre J, Das-Munshi J, et al. Associations between depression, arterial stiffness, and metabolic syndrome among adults in the UK Biobank population study: a mediation analysis. JAMA. Psychiatry. 2020;77:598-606.</mixed-citation><mixed-citation xml:lang="en">Dregan A, Rayner L, Davis KAS, Bakolis I, Arias de la Torre J, Das-Munshi J, et al. Associations between depression, arterial stiffness, and metabolic syndrome among adults in the UK Biobank population study: a mediation analysis. JAMA. Psychiatry. 2020;77:598-606.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Dunbar JA, Reddy P, Davis-Lameloise N, Philpot B, Laatikainen T, Kilkkinen A, Bunker SJ, Best JD, Vartiainen E, Kai Lo S, Janus ED. Depression: an important comorbidity with metabolic syndrome in a general population. Diabetes Care. 2008;31(12):2368-73. https://doi.org/10.2337/dc08-0175.</mixed-citation><mixed-citation xml:lang="en">Dunbar JA, Reddy P, Davis-Lameloise N, Philpot B, Laatikainen T, Kilkkinen A, Bunker SJ, Best JD, Vartiainen E, Kai Lo S, Janus ED. Depression: an important comorbidity with metabolic syndrome in a general population. Diabetes Care. 2008;31(12):2368-73. https://doi.org/10.2337/dc08-0175.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">East C, Willis BL, Barlow CE, Grannemann BD, FitzGerald SJ, DeFina LF, et al. Depressive symptoms and metabolic syndrome in preventive healthcare: the Cooper Center longitudinal study. Metab Syndr Relat Disord. 2010;8:451-457.</mixed-citation><mixed-citation xml:lang="en">East C, Willis BL, Barlow CE, Grannemann BD, FitzGerald SJ, DeFina LF, et al. Depressive symptoms and metabolic syndrome in preventive healthcare: the Cooper Center longitudinal study. Metab Syndr Relat Disord. 2010;8:451-457.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Eckel RH, Alberti KG, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2010;375:181-183.</mixed-citation><mixed-citation xml:lang="en">Eckel RH, Alberti KG, Grundy SM, Zimmet PZ. The metabolic syndrome.  Lancet.  2010;375:181-183.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Fahed G, Aoun L, Bou Zerdan M, Allam S, Bou Zerdan M, Bouferraa Y, Assi HI. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Int J Mol Sci. 2022;23(2):786. https://doi.org/10.3390/ijms23020786.</mixed-citation><mixed-citation xml:lang="en">Fahed G, Aoun L, Bou Zerdan M, Allam S, Bou Zerdan M, Bouferraa Y, Assi HI. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Int J Mol Sci. 2022;23(2):786. https://doi.org/10.3390/ijms23020786.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Fathallah N, Slim R, Larif S, Hmouda H, Ben Salem C. Drug-Induced Hyperglycaemia and Diabetes. Drug Saf. 2015;38(12):1153-68. https://doi.org/10.1007/s40264-015-0339-z.</mixed-citation><mixed-citation xml:lang="en">Fathallah N, Slim R, Larif S, Hmouda H, Ben Salem C. Drug-Induced Hyperglycaemia and Diabetes. Drug Saf. 2015;38(12):1153-68. https://doi.org/10.1007/s40264-015-0339-z.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Ferriani LO, Alves Silva D, Viana MC. Atypical depression is associated with metabolic syndrome: a systematic review. Actas Esp Psiquiatr. 2022;50(6):266-275.</mixed-citation><mixed-citation xml:lang="en">Ferriani LO, Alves Silva D, Viana MC. Atypical depression is associated with metabolic syndrome: a systematic review. Actas Esp Psiquiatr. 2022;50(6):266-275.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Ferriani LO, Silva DA, Molina MDCB, Mill JG, Brunoni AR, da Fonseca MJM, Moreno AB, Benseñor IM, de Aguiar OB, Barreto SM, Viana MC. Depression is a risk factor for metabolic syndrome: Results from the ELSA-Brasil cohort study. J Psychiatr Res. 2023;158:56-62. https://doi.org/10.1016/j.jpsychires.2022.12.017.</mixed-citation><mixed-citation xml:lang="en">Ferriani LO, Silva DA, Molina MDCB, Mill JG, Brunoni AR, da Fonseca MJM, Moreno AB, Benseñor IM, de Aguiar OB, Barreto SM, Viana MC. Depression is a risk factor for metabolic syndrome: Results from the ELSA-Brasil cohort study. J Psychiatr Res. 2023;158:56-62. https://doi.org/10.1016/j.jpsychires.2022.12.017.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Fjukstad KK, Engum A, Lydersen S, Dieset I, Steen NE, Andreassen OA, et al. Metabolic Abnormalities Related to Treatment with Selective Serotonin Reuptake Inhibitors in Patients with Schizophrenia or Bipolar Disorder. J Clin Psychopharmacol. 2016;36(6):615-620.</mixed-citation><mixed-citation xml:lang="en">Fjukstad KK, Engum A, Lydersen S, Dieset I, Steen NE, Andreassen OA, et al.  Metabolic Abnormalities Related to Treatment with Selective Serotonin Reuptake Inhibitors in Patients with Schizophrenia or Bipolar Disorder.  J Clin Psychopharmacol.  2016;36(6):615-620.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Fjukstad KK, Engum A, Lydersen S, Dieset I, Steen NE, Andreassen OA, et al. Metabolic risk factors in schizophrenia and bipolar disorder: The effect of comedication with selective serotonin reuptake inhibitors and antipsychotics. Eur Psychiatry. 2018;48:71-78.</mixed-citation><mixed-citation xml:lang="en">Fjukstad KK, Engum A, Lydersen S, Dieset I, Steen NE, Andreassen OA, et al.  Metabolic risk factors in schizophrenia and bipolar disorder: The effect of comedication with selective serotonin reuptake inhibitors and antipsychotics.  Eur Psychiatry.  2018;48:71-78.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Gawlik-Kotelnicka O, Strzelecki D. Probiotics as a Treatment for «Metabolic Depression»? A Ratio- nale for Future Studies. Pharmaceuticals (Basel). 2021;14(4):384. https://doi.org/10.3390/ph14040384.</mixed-citation><mixed-citation xml:lang="en">Gawlik-Kotelnicka O, Strzelecki D. Probiotics as a Treatment for «Metabolic Depression»? A Ratio- nale for Future Studies. Pharmaceuticals (Basel). 2021;14(4):384. https://doi.org/10.3390/ph14040384.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Gawlik-Kotelnicka O, Strzelecki D. Probiotics as a Treatment for «Metabolic Depression»? A Ratio- nale for Future Studies. Pharmaceuticals (Basel). 2021;14(4):384. https://doi.org/10.3390/ph14040384.</mixed-citation><mixed-citation xml:lang="en">Gawlik-Kotelnicka O, Strzelecki D. Probiotics as a Treatment for «Metabolic Depression»? A Ratio- nale for Future Studies. Pharmaceuticals (Basel). 2021;14(4):384. https://doi.org/10.3390/ph14040384.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Ghanei Gheshlagh R, Parizad N, Sayehmiri K. The relationship between depression and metabolic syndrome: systematic review and meta-analysis study. Iran Red Crescent Med J. 2016;18:e26523.</mixed-citation><mixed-citation xml:lang="en">Ghanei Gheshlagh R, Parizad N, Sayehmiri K. The relationship between depression and metabolic syndrome: systematic review and meta-analysis study. Iran Red Crescent Med J. 2016;18:e26523.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Goldbacher EM, Bromberger J, Matthews KA. Life- time history of major depression predicts the development of the metabolic syndrome in middle-aged women. Psychosom Med. 2009;71:266-272.</mixed-citation><mixed-citation xml:lang="en">Goldbacher EM, Bromberger J, Matthews KA. Life- time history of major depression predicts the development of the metabolic syndrome in middle-aged women. Psychosom Med. 2009;71:266-272.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Grundy SM. Obesity, Metabolic Syndrome, and Cardiovascular Disease. J Clin Endocrinol Metab. 2004;89(6):2595-2600.</mixed-citation><mixed-citation xml:lang="en">Grundy SM. Obesity, Metabolic Syndrome, and Cardiovascular Disease. J Clin Endocrinol Metab. 2004;89(6):2595-2600.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Hiles SA, Révész D, Lamers F, Giltay E, Penninx BW. Bidirectional prospective associations of metabolic syndrome components with depression, anxiety, and antidepressant usE. Depress Anxiety. 2016;33(8):754-64. https://doi.org/10.1002/da.22512.</mixed-citation><mixed-citation xml:lang="en">Hiles SA, Révész D, Lamers F, Giltay E, Penninx BW. Bidirectional prospective associations of metabolic syndrome components with depression, anxiety, and antidepressant usE. Depress Anxiety. 2016;33(8):754-64. https://doi.org/10.1002/da.22512.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Hirtz R, Libuda L, Hinney A, Focker M, Buhlmeier J, Antel J, et al. Lack of evidence for a relationship between the hypothalamus-pituitary-adrenal and the hypothalamus-pituitary-thyroid axis in adolescent depression. Front Endocrinol. 2021;12:662243.</mixed-citation><mixed-citation xml:lang="en">Hirtz R, Libuda L, Hinney A, Focker M, Buhlmeier J, Antel J, et al. Lack of evidence for a relationship between the hypothalamus-pituitary-adrenal and the hypothalamus-pituitary-thyroid axis in adolescent depression. Front Endocrinol. 2021;12:662243.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">International Diabetes Federation—IDF. Information on the IDF consensus worldwide definition of the metabolic syndrome. [idf.org]. idf; 2006. Available: http://www.idf.org/e-library/consensus-statements/60-idfconsensus-worldwide-definitionof-the-metabolic-syndrome.html</mixed-citation><mixed-citation xml:lang="en">International Diabetes Federation—IDF. Information on the IDF consensus worldwide definition of the metabolic syndrome. [idf.org]. idf; 2006. Available: http://www.idf.org/e-library/consensus-statements/60-idfconsensus-worldwide-definitionof-the-metabolic-syndrome.html</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Jellinger KA. Pathomechanisms of Vascular Depression in Older Adults. Int J Mol Sci. 2021;23(1):308.</mixed-citation><mixed-citation xml:lang="en">Jellinger KA. Pathomechanisms of Vascular Depression in Older Adults. Int J Mol Sci. 2021;23(1):308.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Kim SY, Park JH, Lee MY, Oh KS, Shin DW, Shin YC. Physical activity and the prevention of depression: a cohort study. Gen Hosp Psychiatry. 2019;60:90-97.</mixed-citation><mixed-citation xml:lang="en">Kim SY, Park JH, Lee MY, Oh KS, Shin DW, Shin YC. Physical activity and the prevention of depression: a cohort study. Gen Hosp Psychiatry. 2019;60:90-97.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Kim Y, Kim HY. Association between depression and metabolic syndrome in Korean adults: data from the 2014 and 2016 Korea National Health and Nutrition Examination Survey. Asia Pac J Public Health. 2019;31:18-29.</mixed-citation><mixed-citation xml:lang="en">Kim Y, Kim HY. Association between depression and metabolic syndrome in Korean adults: data from the 2014 and 2016 Korea National Health and Nutrition Examination Survey. Asia Pac J Public Health. 2019;31:18-29.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Kim JY, Yi ES. Analysis of the relationship between physical activity and metabolic syndrome risk fac- tors in adults with intellectual disabilities. J Exerc Rehabil. 2018;14(4):592-597. https://doi.org/10.12965/jer.1836302.151.</mixed-citation><mixed-citation xml:lang="en">Kim JY, Yi ES. Analysis of the relationship between physical activity and metabolic syndrome risk fac- tors in adults with intellectual disabilities. J Exerc Rehabil. 2018;14(4):592-597. https://doi.org/10.12965/jer.1836302.151.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Kinder LS, Carnethon MR, Palaniappan LP, King AC, Fortmann SP. Depression and the metabolic syndrome in young adults: Findings from the Third National Health and Nutrition Examination Survey. Psychosom Med. 2004;66(3):316-322.</mixed-citation><mixed-citation xml:lang="en">Kinder LS, Carnethon MR, Palaniappan LP, King AC, Fortmann SP. Depression and the metabolic syndrome in young adults: Findings from the Third National Health and Nutrition Examination Survey. Psychosom Med. 2004;66(3):316-322.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Koponen H, Jokelainen J, Keinänen Kiukaanniemi S, Kumpusalo E, Vanhala M. Metabolic syndrome predisposes to depressive symptoms: a population-based 7-year follow-up study. J Clin Psychiatry. 2008;69:178-182.</mixed-citation><mixed-citation xml:lang="en">Koponen H, Jokelainen J, Keinänen Kiukaanniemi S, Kumpusalo E, Vanhala M. Metabolic syndrome predisposes to depressive symptoms: a population-based 7-year follow-up study. J Clin Psychiatry. 2008;69:178-182.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Liu CS, Carvalho AF, McIntyre RS. Towards a «metabolic» subtype of major depressive disorder: shared pathophysiological mechanisms may contribute to cognitive dysfunction. CNS Neurol Disord Drug Targets. 2014;13(10):1693-707.</mixed-citation><mixed-citation xml:lang="en">Liu CS, Carvalho AF, McIntyre RS. Towards a «metabolic» subtype of major depressive disorder: shared pathophysiological mechanisms may contribute to cognitive dysfunction. CNS Neurol Disord Drug Targets. 2014;13(10):1693-707.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Marazziti D, Arone A, Palermo S, Annuzzi E, Cappellato G, Chiarantini I, Prete LD, Dell’Osso L. The Wicked Relationship between Depression and Metabolic Syndrome. Clin Neuropsychiatry. 2023;20(2):100-108. https://doi.org/10.36131/cnfioritieditore20230202.</mixed-citation><mixed-citation xml:lang="en">Marazziti D, Arone A, Palermo S, Annuzzi E, Cappellato G, Chiarantini I, Prete LD, Dell’Osso L. The Wicked Relationship between Depression and Metabolic Syndrome. Clin Neuropsychiatry. 2023;20(2):100-108. https://doi.org/10.36131/cnfioritieditore20230202.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Matta J, Hoertel N, Kesse-Guyot E, Plesz M, Wiernik E, Carette C, et al. Diet and physical activity in the association between depression and metabolic syndrome: constances study. J Affect Disord. 2019;244:25-32.</mixed-citation><mixed-citation xml:lang="en">Matta J, Hoertel N, Kesse-Guyot E, Plesz M, Wiernik E, Carette C, et al. Diet and physical activity in the association between depression and metabolic syndrome: constances study. J Affect Disord. 2019;244:25-32.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Mazereel V, Detraux J, Vancampfort D, van Winkel R, De Hert M. Impact of psychotropic medication effects on obesity and the metabolic syndrome in people with serious mental illness. Front Endocri- nol. 2020;11:573479.</mixed-citation><mixed-citation xml:lang="en">Mazereel V, Detraux J, Vancampfort D, van Winkel R, De Hert M. Impact of psychotropic medication effects on obesity and the metabolic syndrome in people with serious mental illness. Front Endocri- nol. 2020;11:573479.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">McIntyre RS, Rasgon NL, Kemp DE, Nguyen HT, Law CWY, Taylor VH, et al. Metabolic syndrome and major depressive disorder: co-occurrence and pathophysiologic overlap. Curr Diab Rep. 2009;9:51-59.</mixed-citation><mixed-citation xml:lang="en">McIntyre RS, Rasgon NL, Kemp DE, Nguyen HT, Law CWY, Taylor VH, et al. Metabolic syndrome and major depressive disorder: co-occurrence and pathophysiologic overlap. Curr Diab Rep. 2009;9:51-59.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Miettola J, Niskanen LK, Viinamaki H, Kumpusalo E. Metabolic syndrome is associated with self-perceived depression. Scand J Prim Health Care. 2008;26(4):203-210.</mixed-citation><mixed-citation xml:lang="en">Miettola J, Niskanen LK, Viinamaki H, Kumpusalo E. Metabolic syndrome is associated with self-perceived depression. Scand J Prim Health Care. 2008;26(4):203-210.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Moradi Y, Albatineh AN, Mahmoodi H, Gheshlagh RG. The relationship between depression and risk of metabolic syndrome: a meta-analysis of observational studies. Clin Diabetes Endocrinol. 2021;7(1):4. https://doi.org/10.1186/s40842-021-00117-8.</mixed-citation><mixed-citation xml:lang="en">Moradi Y, Albatineh AN, Mahmoodi H, Gheshlagh RG. The relationship between depression and risk of metabolic syndrome: a meta-analysis of observational studies. Clin Diabetes Endocrinol. 2021;7(1):4. https://doi.org/10.1186/s40842-021-00117-8.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Nayerifard R, Bureng MA, Zahiroddin A, Namjoo M, Rajezi S. Comparison of metabolic syndrome prevalence in patients with schizophrenia and bipolar I disorder. Diabetes Metab Syndr. 2017;11(Suppl 1):411-416. https://doi.org/10.1016/j.dsx.2017.03.027.</mixed-citation><mixed-citation xml:lang="en">Nayerifard R, Bureng MA, Zahiroddin A, Namjoo M, Rajezi S. Comparison of metabolic syndrome prevalence in patients with schizophrenia and bipolar I disorder. Diabetes Metab Syndr. 2017;11(Suppl 1):411-416. https://doi.org/10.1016/j.dsx.2017.03.027.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Olvera RL, Williamson DE, Fisher-Hoch SP, Vatcheva KP, McCormick JB. Depression, obesity, and metabolic syndrome: prevalence and risks of comorbidity in a population-based representative sample of Mexican Americans. J Clin Psychiatry. 2015;76:e1300-1305.</mixed-citation><mixed-citation xml:lang="en">Olvera RL, Williamson DE, Fisher-Hoch SP, Vatcheva KP, McCormick JB. Depression, obesity, and metabolic syndrome: prevalence and risks of comorbidity in a population-based representative sample of Mexican Americans. J Clin Psychiatry. 2015;76:e1300-1305.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Pan A, Keum N, Okereke OI, Sun Q, Kivimaki M, Rubin RR, et al. Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Diabetes Care. 2012;35:1171-1180.</mixed-citation><mixed-citation xml:lang="en">Pan A, Keum N, Okereke OI, Sun Q, Kivimaki M, Rubin RR, et al. Bidirectional association between depression and metabolic syndrome: a systematic review and meta-analysis of epidemiological studies. Diabetes Care. 2012;35:1171-1180.</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Peters T, Nüllig L, Antel J, Naaresh R, Laabs BH, Tegeler L, Amhaouach C, Libuda L, Hinney A, Hebebrand J. The Role of Genetic Variation of BMI, Body Composition, and Fat Distribution for Mental Traits and Disorders: A Look-Up and Mendelian Randomization Study. Front Genet. 2020;11:373. https://doi.org/10.3389/fgene.2020.00373.</mixed-citation><mixed-citation xml:lang="en">Peters T, Nüllig L, Antel J, Naaresh R, Laabs BH, Tegeler L, Amhaouach C, Libuda L, Hinney A, Hebebrand J. The Role of Genetic Variation of BMI, Body Composition, and Fat Distribution for Mental Traits and Disorders: A Look-Up and Mendelian Randomization Study. Front Genet. 2020;11:373. https://doi.org/10.3389/fgene.2020.00373.</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Pulkki-Raback L, Elovainio M, Kivimäki M, Matts- son N, Raitakari OT, et al. Depressive symptoms and the metabolic syndrome in childhood and adulthood: a prospective cohort study. Health Psychol. 2009;28:108-116.</mixed-citation><mixed-citation xml:lang="en">Pulkki-Raback L, Elovainio M, Kivimäki M, Matts- son N, Raitakari OT, et al. Depressive symptoms and the metabolic syndrome in childhood and adulthood: a prospective cohort study. Health Psychol. 2009;28:108-116.</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Repousi N, Masana MF, Sanchez-Niubo A, Haro JM, Tyrovolas S. Depression and metabolic syndrome in the older population: A review of evidence. J Affect Disord. 2018;237:56-64. https://doi.org/10.1016/j.jad.2018.04.102.</mixed-citation><mixed-citation xml:lang="en">Repousi N, Masana MF, Sanchez-Niubo A, Haro JM, Tyrovolas S. Depression and metabolic syndrome in the older population: A review of evidence. J Affect Disord. 2018;237:56-64. https://doi.org/10.1016/j.jad.2018.04.102.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Roopan S, Larsen ER. Use of antidepressants in patients with depression and comorbid diabetes mellitus: a systematic review. Acta Neuropsychiatr. 2017;29(3):127-139.</mixed-citation><mixed-citation xml:lang="en">Roopan S, Larsen ER. Use of antidepressants in patients with depression and comorbid diabetes mellitus: a systematic review. Acta Neuropsychiatr. 2017;29(3):127-139.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Salvi V, Grua I, Cerveri G, Mencacci C, Barone-Adesi F. The risk of new-onset diabetes in antidepressant users—A systematic review and meta-analysis. PLoS One. 2017;12(7):e0182088.</mixed-citation><mixed-citation xml:lang="en">Salvi V, Grua I, Cerveri G, Mencacci C, Barone-Adesi F. The risk of new-onset diabetes in antidepressant users—A systematic review and meta-analysis. PLoS One. 2017;12(7):e0182088.</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Silarova B, Giltay EJ, Van Reedt Dortland A, Van Rossum EF, Hoencamp E, Penninx BW, et al. Metabolic syndrome in patients with bipolar disorder: comparison with major depressive disor- der and non-psychiatric controls. J Psychosom Res. 2015;78:391-8.</mixed-citation><mixed-citation xml:lang="en">Silarova B, Giltay EJ, Van Reedt Dortland A, Van Rossum EF, Hoencamp E, Penninx BW, et al. Metabolic syndrome in patients with bipolar disorder: comparison with major depressive disor- der and non-psychiatric controls. J Psychosom Res. 2015;78:391-8.</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Silva DA, Coutinho ESF, Ferriani LO, Viana MC. Depression subtypes and obesity in adults: a systematic review and meta‐analysis. Obes Rev. 2019;21(3):e12966</mixed-citation><mixed-citation xml:lang="en">Silva DA, Coutinho ESF, Ferriani LO, Viana MC. Depression subtypes and obesity in adults: a systematic review and meta‐analysis. Obes Rev. 2019;21(3):e12966</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Stetler C, Miller GE. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom Med. 2011;73:114-26.</mixed-citation><mixed-citation xml:lang="en">Stetler C, Miller GE. Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosom Med. 2011;73:114-26.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Stunkard AJ, Faith MS, Allison KC. Depression and obesity. Biol Psychiatry. 2003;54(3):330-7. https://doi.org/10.1016/s0006-3223(03)00608-5.</mixed-citation><mixed-citation xml:lang="en">Stunkard AJ, Faith MS, Allison KC. Depression and obesity. Biol Psychiatry. 2003;54(3):330-7. https://doi.org/10.1016/s0006-3223(03)00608-5.</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Swarup S, Ahmed I, Grigorova Y, Zeltser R. Metabolic Syndrome. StatPearls. 2024.</mixed-citation><mixed-citation xml:lang="en">Swarup S, Ahmed I, Grigorova Y, Zeltser R. Metabolic Syndrome. StatPearls. 2024.</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Tang B, Yuan S, Xiong Y, He Q, Larsson SC. Major depressive disorder and cardiometabolic diseases: a bidirectional Mendelian randomisation study. Diabetologia. 2020;63:1305-11.</mixed-citation><mixed-citation xml:lang="en">Tang B, Yuan S, Xiong Y, He Q, Larsson SC. Major depressive disorder and cardiometabolic diseases: a bidirectional Mendelian randomisation study. Diabetologia. 2020;63:1305-11.</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Taylor VH, Macqueen GM. The Role of Adipokines in Understanding the Associations between Obesity and Depression. J Obes. 2010;2010:748048.</mixed-citation><mixed-citation xml:lang="en">Taylor VH, Macqueen GM. The Role of Adipokines in Understanding the Associations between Obesity and Depression. J Obes. 2010;2010:748048.</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Van der Pal KC, Koopman ADM, Lakerveld J, van der Heijden AA, Elders PJ, Beulens JW, Rutters F. The association between multiple sleep-related characteristics and the metabolic syndrome in the general population: The New Hoorn study. Sleep Medicine, 2018;52:51-57.</mixed-citation><mixed-citation xml:lang="en">Van der Pal KC, Koopman ADM, Lakerveld J, van der Heijden AA, Elders PJ, Beulens JW, Rutters F. The association between multiple sleep-related characteristics and the metabolic syndrome in the general population: The New Hoorn study. Sleep Medicine, 2018;52:51-57.</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">van Leijden MJ, Penninx B, Agyemang C, Olff M, Adriaanse MC, Snijder MB. The association of depression and posttraumatic stress disorder with the metabolic syndrome in a multi-ethnic cohort: the HELIUS study. Soc Psychiatry Psychiatr Epidemiol. 2018;53:921-930.</mixed-citation><mixed-citation xml:lang="en">van Leijden MJ, Penninx B, Agyemang C, Olff M, Adriaanse MC, Snijder MB. The association of depression and posttraumatic stress disorder with the metabolic syndrome in a multi-ethnic cohort: the HELIUS study. Soc Psychiatry Psychiatr Epidemiol. 2018;53:921-930.</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">van Reedt Dortland AK, Giltay EJ, van Veen T, Zitman FG, Penninx BW. Metabolic syndrome abnormalities are associated with severity of anxiety and depression and with tricyclic antidepressant use. Acta Psychiatr Scand. 2010;122:30-39.</mixed-citation><mixed-citation xml:lang="en">van Reedt Dortland AK, Giltay EJ, van Veen T, Zitman FG, Penninx BW. Metabolic syndrome abnormalities are associated with severity of anxiety and depression and with tricyclic antidepressant use. Acta Psychiatr Scand. 2010;122:30-39.</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Vancampfort D, Correll CU, Wampers M, Sienaert P, Mitchell AJ, De Herdt A, et al. Metabolic syndrome and metabolic abnormalities in patients with major depressive disorder: a meta-analysis of prevalences and moderating variables. Psychol Med. 2014;44:2017-2028.</mixed-citation><mixed-citation xml:lang="en">Vancampfort D, Correll CU, Wampers M, Sienaert P, Mitchell AJ, De Herdt A, et al. Metabolic syndrome and metabolic abnormalities in patients with major depressive disorder: a meta-analysis of prevalences and moderating variables. Psychol Med. 2014;44:2017-2028.</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Vancampfort D, Wampers M, Mitchell AJ, Correll CU, De Herdt A, Probst M, De Hert M. A meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controls. World Psychiatry. 2013;12(3):240-50. https://doi.org/10.1002/wps.20069.</mixed-citation><mixed-citation xml:lang="en">Vancampfort D, Wampers M, Mitchell AJ, Correll CU, De Herdt A, Probst M, De Hert M. A meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controls. World Psychiatry. 2013;12(3):240-50. https://doi.org/10.1002/wps.20069.</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Vanhala M, Jokelainen J, Keinanen-Kiukaanniemi S, Kumpusalo E, Koponen H. Depressive symptoms predispose females to metabolic syndrome: a 7-year follow-up study. Acta Psychiatr Scand. 2009;119:137-142.</mixed-citation><mixed-citation xml:lang="en">Vanhala M, Jokelainen J, Keinanen-Kiukaanniemi S, Kumpusalo E, Koponen H. Depressive symptoms predispose females to metabolic syndrome: a 7-year follow-up study. Acta Psychiatr Scand. 2009;119:137-142.</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Virtanen M, Ferrie JE, Akbaraly T, Tabak A, Jokela M, Ebmeier KP, et al. Metabolic syndrome and symptom resolution in depression: a 5-year follow-up of older adults. J Clin Psychiatry. 2017;78:e1-e7.</mixed-citation><mixed-citation xml:lang="en">Virtanen M, Ferrie JE, Akbaraly T, Tabak A, Jokela M, Ebmeier KP, et al. Metabolic syndrome and symptom resolution in depression: a 5-year follow-up of older adults. J Clin Psychiatry. 2017;78:e1-e7.</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Woo YS, McIntyre RS, Kim JB et al. Association of treatment response with obesity and other metabolic risk factors in adults with depressive disorders: Results from a National Depression Cohort study in Korea (the CRESCEND study). J Affect Disord. 2016;203:190-198.</mixed-citation><mixed-citation xml:lang="en">Woo YS, McIntyre RS, Kim JB et al.  Association of treatment response with obesity and other metabolic risk factors in adults with depressive disorders: Results from a National Depression Cohort study in Korea (the CRESCEND study).  J Affect Disord.  2016;203:190-198.</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">World Health Organization—WHO. Depression and Other Common Mental Disorders: Global Health Estimates. [who.int]. who; 2017. Available: https://www.who.int/publications/i/item/depression-global-health-estimates</mixed-citation><mixed-citation xml:lang="en">World Health Organization—WHO. Depression and Other Common Mental Disorders: Global Health Estimates. [who.int]. who; 2017. Available: https://www.who.int/publications/i/item/depression-global-health-estimates</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Xu Q, Anderson D, Lurie-Beck J. The relationship between abdominal obesity and depression in the general population: a systematic review and meta-analysis. Obes Res Clin Pr. 2011;5:e267-360.</mixed-citation><mixed-citation xml:lang="en">Xu Q, Anderson D, Lurie-Beck J. The relationship between abdominal obesity and depression in the general population: a systematic review and meta-analysis. Obes Res Clin Pr. 2011;5:e267-360.</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang M, Chen J, Yin Z, Wang L, Peng L. The association between depression and metabolic syndrome and its components: a bidirectional two-sample Mendelian randomization study. Transl Psychiatry. 2021;11(1):633. https://doi.org/10.1038/s41398-021-01759-z.</mixed-citation><mixed-citation xml:lang="en">Zhang M, Chen J, Yin Z, Wang L, Peng L. The association between depression and metabolic syndrome and its components: a bidirectional two-sample Mendelian randomization study. Transl Psychiatry. 2021;11(1):633. https://doi.org/10.1038/s41398-021-01759-z.</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Zhong Z, Wang L, Wen X, Liu Y, Fan Y, Liu Z. A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials. Neuropsychiatr Dis Treat. 2017;13:2781-2796.</mixed-citation><mixed-citation xml:lang="en">Zhong Z, Wang L, Wen X, Liu Y, Fan Y, Liu Z. A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials. Neuropsychiatr Dis Treat. 2017;13:2781-2796.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
